Background: The effect of breastfeeding (BF) on cardiometabolic risk factors is not well characterized.
Introduction
Mexico has low rates of breastfeeding (BF) 8 . Between 1999 and 2012 the prevalence of exclusive BF (EBF) at <6 mo decreased from 20.3% (1) to 14.4% (2) , predominant BF (PreBF) from 33.5% to 25.0%, and continued BF up to 2 y of age from 25.1% to 14.1%. At the same time, the prevalence of overweight and obesity in Mexican children has increased. Between 1988 and 2012, overweight in children <5 y of age (BMI z score > 2.0) increased from 7.8% to 9.7% (3) , and the combined prevalence of overweight and obesity (BMI z score > 1.0) in school-aged children (5-11 y) increased between 1999 and 2012 from 25.5% to 32.0% in girls and from 28.2% to 36.9% in boys (3) .
Obesity is a multifactorial condition. Early infant nutrition is one of the most important factors that determine growth patterns during early life and therefore is potentially associated with obesity. Epidemiologic studies have documented associations between infant feeding practices and the risk of obesity (4, 5) . Systematic reviews and meta-analyses of observational studies of the short-and long-term effects of BF document modest protective associations with overweight and obesity, hypertension, and serum cholesterol (6) . However, the only randomized controlled trial (7) did not find a protective effect of BF on adiposity or cardiovascular disease risk indicators at 6 y of age. Inconsistencies across studies (8) (9) (10) ) may reflect differences in definitions of BF, overweight, and obesity; inadequate control for potential confounding factors [such as obesity of parents, maternal smoking, and socioeconomic status (SES)]; or recall bias in studies that retrospectively document feeding practices.
In addition, the low and declining BF rates and the increase in the prevalence of overweight and obesity, in Mexico and elsewhere, support the need to clarify the role of BF in the prevention of obesity.
Therefore, the objective of the present study was to evaluate the association between BF practices and indicators of adiposity and cardiometabolic risk at 4 y of age in a well-characterized prospective study.
Methods

Study design and population
We studied the offspring of women who participated in the Prenatal Omega-3 Fatty Acid Supplementation and Child Growth And Development Study, in which pregnant women living in Cuernavaca, Mexico, were randomly assigned to receive daily either 400 mg of DHA (22:6n-3) or a placebo from mid-pregnancy to delivery (11) . The original objective of the study was to evaluate the effect of prenatal DHA supplementation during pregnancy on the offspringÕs cognitive development. Mother-child pairs were followed prospectively. A total of 1094 women were recruited at the Mexican Social Security Institute General Hospital I, located in Cuernavaca, Mexico. Women were randomly assigned to receive the DHA supplements or a placebo from 18 to 22 wk of pregnancy to delivery (11) .
The original study included 978 live births between June 2005 and June 2007 to 973 women (5 women delivered twins) who remained in the study through parturition. For this analysis we considered the sample of children with follow-up information at 4 y (data collection 2009-2011), of whom 727 children had complete information on anthropometry and 524 provided a blood sample and had information on the biomarkers of interest. With this last sample size we have 80% power to detect correlations of $0.12 at a 2-tailed significance level of 0.05.
The study was approved by the Human Research Ethics Committees at the National Institute of Public Health in Mexico and Emory University in Atlanta, GA. Written informed consent was obtained from all women at each stage of the study, and verbal assent was obtained from the children as appropriate.
Data collection and laboratory methods Sociodemographic characteristics. At recruitment, a questionnaire was administered to the mothers to obtain information related to housing, sanitation, and possession of household goods. The variables used in the index included housing characteristics (floor, wall, and roofing materials), water and sanitation services, possession of household goods (radio, television, videotape player, digital video disc player, refrigerator, washing and dryer machines, microwave, car, motorcycle, computer, phone, and stereo), and overcrowding (number of people living in the house/number of rooms available). This information was used to build a socioeconomic index by using principal components analysis (11) . Only the first component was used, which explained 19% of the total variance.
Anthropometric measurements. Weight, height, abdominal circumference (AC), subscapular skinfold thickness (SSF), and triceps skinfold thickness (TSF) were measured in children at 4 y of age by using standardized procedures (12, 13) . Weight was measured with a portable electronic pediatric scale with a precision of 100 g and was calibrated daily with a known reference weight. Children were weighed twice with a minimum amount of clothes. Height was measured with a stadiometer with a precision of 1.0 mm. AC was obtained with a fiberglass tape measure with a precision of 1.0 mm. SSF and TSF were measured in triplicate to the nearest 1.0 mm on the nondominant side of the body with a Lange skinfold caliper, while applying a constant pressure of 10 g/ mm 2 ; the mean value was used in analyses.
Lipid, glucose, and insulin profiles. Lipid, glucose, and insulin profiles were determined from an aliquot of serum obtained from nonfasting blood samples taken through venipuncture. TGs, total cholesterol, cholesterol fractions (HDL), serum glucose, and insulin were measured with an automated system (Synchron; Beckman Coulter Mark). Total cholesterol and TGs were determined with an enzymatic method; HDL cholesterol was isolated by precipitation with phosphotungstic acid and magnesium chloride solution. LDL cholesterol was calculated with the Friedewald formula (14) . Insulin was determined by an enzyme immunoassay, and glucose was determined with the glucose oxidase test.
Breastfeeding. At the 3-mo follow-up, mothers were interviewed about BF and intake of nonhuman milk, liquids, and foods with questions such as: Do you breastfeed the baby? Do you feed the baby with milk that is not breast milk? Do you feed him or her with liquids that do not contain milk? What other liquids do you give the baby? Do you give the baby other food? These questions were used to categorize BF status at 3 mo of age according to the WHO classification (15) as EBF, defined as the intake of breast milk only, allowing the consumption of drops, syrups, oral rehydration solution, and/or vitamins and minerals; PreBF, defined as the intake of breast milk plus certain fluids such as water, water-based drinks (sweetened and flavored water, teas, infusions, etc.), fruit juices, oral rehydration solution, and vitamins and/or minerals; partial BF (PaBF), defined as breast milk plus any food or liquid, including nonhuman milk; and non-BF (NBF), defined as the intake of formula or other nonhuman milk and/or solid foods without BF. At the 24-mo follow-up the mother was asked about the age at which she stopped BF the child. Total duration of BF was classified as <3 mo, 3-6 mo, >6 to 12 mo, and >12 mo.
Study variables
We considered the following 9 outcome variables: BMI (in kg/m 2 ); sum of SSF and TSF; AC; and serum concentration of TGs, total cholesterol, LDL cholesterol, HDL cholesterol, glucose, and insulin. All the outcome variables were modeled as continuous. Insulin, sum of SSF and TSF, and TGs were logarithmically transformed before analyses.
Data analysis
To reduce the number of outcome variables and to simplify the analysis, we considered the internal patterns of association among the 9 variables and grouped variables that were highly related to each other by using principal components and factor analyses. We concluded that the adiposity variables (BMI, sum of SSF and TSF, and AC) constituted a single group (group 1), whereas the cardiometabolic markers clustered in 3 groups: total cholesterol, HDL cholesterol, and LDL cholesterol (group 2); TGs (group 3); and glucose and insulin (group 4). Therefore, analyses were based on these 4 groups. The groups of variables explained 86.0%, 36.0%, 17.0%, and 26.0% of variance, for groups 1, 2, 3, and 4, respectively.
We used path analysis to evaluate direct and indirect association patterns between BF and each group of dependent variables. Path analysis is an extension from linear models whereby direct and indirect pathways (or associations) can be estimated and tested explicitly. It therefore provides a level of simultaneous analysis not readily feasible by using ordinary linear regression approaches, in which only direct paths are estimated (16, 17) .
We built separate path models for each outcome variable group, including predictor variables as derived from the literature (18-23) (Supplemental Figure 1) . We adjusted the models for maternal SES, schooling, BMI at recruitment (gestation weeks [18] [19] [20] [21] [22] , smoking status at recruitment, and treatment assignment group (DHA vs. placebo); and child birth weight, sex, and age at follow-up. For the biomarker models we also adjusted for hours of fasting before the blood draw. All variables were included a priori, based on the conceptual model, and were maintained even if not statistically significant. Other variables considered for the conceptual model but were not available in the data set included maternal weight gain during pregnancy, postpartum smoking, and child dietary and physical activity information.
Models were fitted with the sample with complete data for the covariates and the outcome variable(s) of interest. We compared children included and those excluded from the analyses to evaluate potential biases due to attrition.
To address the potential for residual confounding we identified positive potential confounding factors (factors associated both with the exposure and outcome variables in the same direction, regardless of their P values) (24) . All of these variables were included in the models.
The goodness of fit to the data was evaluated in all models through evaluation of likelihood ratio (model vs. saturated model), root mean squared error of approximation, and comparative fit index. Statistical analyses were performed with STATA 12.0 (Stata Corporation).
Results
We analyzed the data of 611 children with complete information on BF status, covariates of interest, and outcomes for adiposity and 446 children with complete information on BF status, covariates of interest, and cardiometabolic markers (Figure 1) . These numbers are 63% and 45.8%, respectively, of the total sample of children studied at 4 y. The analyzed sample did not differ from those excluded for 8 of 9 baseline characteristics (Supplemental Table 1 ).
General characteristics of the study population are shown in Table 1 . One of 8 children at 3 mo was breastfed exclusively, and 46% of children continued to receive breast milk beyond 6 mo. The mean BMI was close to the reference median of 15.3 for boys and 15.2 for girls (25) , and the cardiometabolic risk markers (insulin, glucose, TGs, total cholesterol, HDL cholesterol, LDL cholesterol) were generally within normal concentrations (26, 27) .
We combined EBF and PreBF as a single category for analysis (referred to hereafter as EBF-PreBF) because in preliminary analyses we found that outcomes did not differ between these categories.
Our analysis of the confounding structure patterns identified maternal DHA assignment, SES, schooling, BMI, smoking during pregnancy, and child birth weight as positive potential confounding factors. The associations did not change substantially as a result of including or excluding these potential confounding factors.
Coefficients from the path models are presented in Figure 1 and Tables 2 and 3. Coefficients are presented as direct, indirect, and total effects. Figure 1 shows 2 path models in explicit form. These models show the statistically significant pathways among study variables and the path coefficients of major interest. The coefficients represent the mean differences in outcome variables among categories of the explanatory variables in outcome variable units. In the case of log-transformed variables (such as sum of SSF and TSF and insulin and TG concentrations), the path coefficients are interpreted as percentage of change (e.g., a coefficient of 0.04 should be interpreted as a 4% increase).
Children who were NBF or PaBF at 3 mo had higher BMI, sum of SSF and TSF, and AC than the EBF-PreBF group ( Figure  1A , Supplemental Figure 1A , and Table 3 ). For the lipid profile, NBF children had higher serum concentrations of total cholesterol and LDL cholesterol and higher percentage of change in TGs than the EBF-PreBF group, although for the 2 latter markers this difference was marginal (P = 0.09 and P = 0.08, respectively). In addition, the association between BF status and lipid profiles was not mediated by adiposity.
Children who were PaBF or NBF had higher percentage of change in insulin than the EBF-PreBF group; however, the direct pathways were not statistically significant (P = 0.76 and P = 0.25, respectively), whereas the indirect pathways mediated through AC were statistically significant (P < 0.05). PaBF children had 4% higher insulin concentrations than EBF children, whereas NBF children had 7% higher insulin concentrations relative to the EBF category. These associations were both mediated through AC.
Direct and indirect associations with glucose concentrations were not statistically significant (P > 0.05) ( Figure 1B , Supplemental Figure 1B , and Table 3 ).
For duration of BF, children who were breastfed for <3 mo had significantly higher BMI, sum of SSF and TSF, and AC than children who were breastfed for >12 mo (Table 2 ). No differences were found between other categories of duration of BF in comparison with children breastfed for >12 mo (P = 0.13-0.30). In addition, we observed a significant inverse association between all the adiposity indicators and duration of BF (all P-trends: <0.05). However, no significant association was found between duration of BF and any of the cardiometabolic markers (P = 0.23-0.98).
Discussion
Our results show that Mexican children who were PaBF or NBF at 3 mo of age had higher adiposity and higher serum insulin concentrations at 4 y of age than children in the EBF-PreBF group at 3 mo. In addition, children who were NBF at 3 mo had higher serum concentrations of total cholesterol at 4 y than the group who was EBF-PreBF at 3 mo. Duration of BF >12 mo was FIGURE 2 Simplified path models of the relation of breastfeeding status at 3 mo of age with adiposity, insulin, and glucose in children at 4 y of age. Arrows represent pathways among variables that were statistically significant. The bold arrows and the path coefficients show the significant associations that are relevant to the study objectives (*P # 0.05). EBF or PreBF are the categories of reference. (A) The direct relations between breastfeeding status at 3 mo and adiposity at 4 y of age that were statistically significant are shown. Values are differences in BMI (in kg/m 2 ), SSF (in log mm), and AC (in cm) between the NBF and PaBF categories and the EBF/PreBF category, respectively. (B) The indirect relation between breastfeeding status at 3 mo and insulin at 4 y of age which was mediated by AC is shown. Values are mean differences across categories for insulin (in log mU/mL). AC, abdominal circumference; EBF, exclusive breastfeeding; NBF, nonbreastfeeding; PaBF, partial breastfeeding; PreBF, predominant breastfeeding; Smoking, smoking during pregnancy (weeks 18-22); SES, socioeconomic status; SFT, sum of SSF and TSF (in mm); SSF, subscapular skinfold thickness; TSF, triceps skinfold thickness.
inversely associated with adiposity but not with cardiometabolic markers.
Our results are consistent with other recent observational studies in 8 European countries (28) and Australia (29) . Our findings about the duration of BF are also consistent with several published studies (18, 30, 31) , which found elevated prevalence of overweight in children who were breastfed for <3 mo compared with children who were breastfed for $3 mo. One previous study found that BF for >12 mo was inversely associated with adiposity (18) . However, our findings differ from the results of a large randomized controlled trial of the promotion of BF, which showed no effect of BF TSF, triceps skinfold thickness. 2 Total effects correspond to direct effects because no significant indirect effects were found in path analysis. 3 Adjusted for maternal BMI at 18-22 wk of pregnancy; smoking status during pregnancy; education; socioeconomic status; DHA treatment; imputed data for duration of breastfeeding; and child birth weight, sex, and age (n = 671). 4 Additionally adjusted for hours of fasting (n = 487). 5 Additionally adjusted for hours of fasting (n = 508).
status at 3 mo on mean BMI, skinfold thicknesses, or obesity at age 6.5 y (7). Our results on the association between BF and insulin, mediated via AC, is plausible, given that intra-abdominal adipose tissue is associated with greater resistance to insulin than is subcutaneous fat (32) . Others studies in children have documented an association between body or visceral fat and insulin resistance (33, 34) and an association between insulin and AC (35) .
Infant feeding practices may program long-term changes in cholesterol metabolism. A systematic review of observational studies found that any EBF (the review did not examine associations with duration of EBF) was associated with lower blood cholesterol concentrations in adults (19) . More recently, a crosssectional study in children 5-11 y of age also documented similar associations (36) . We identified only 1 cohort study that examined BF status in relation to the lipid profiles of children at 4 y of age in a contemporary cohort (37) ; that study did not find any relation after adjustment for maternal pregnancy BMI and socioeconomic position. Inconsistencies across studies may reflect residual confounding or limitations of sample size.
Inconsistencies among studies may reflect differences in the social patterning of BF. A systematic review showed that BF was associated with slightly lower mean BMI than formula feeding (38) . However, when the results were adjusted for SES, maternal smoking in pregnancy, and maternal BMI, the association disappeared. Brion et al. (39) showed how associations from observational studies may be explained by residual confounding. They documented differing social patterning of BF and obesity in Britain and Brazil, showing that duration of BF was associated with lower BMI only in the British population but not in Brazil, where BF patterns did not differ by socioeconomic position and the socioeconomic position-BMI association was in the opposite direction from the British context (39) . Breastfeeding patterns in Mexico differ by socioeconomic position. At the national level, the lowest SES tertile has higher prevalences of EBF and PreBF at 6 mo as well as longer duration of BF than the upper SES tertiles (40) . In addition, BMI in Mexican infants is associated with lower prevalence of EBF at 4 and 6 mo and lower duration of BF (41) . These results suggest the need for careful modeling of relations, including a wide set of well-defined covariates. We adjusted for several variables that were documented in the literature and for potentially confounding variables that were identified in our analysis of the confounding structure patterns in our sample. Although there is always the possibility for residual confounding in an observational study, given that associations did not change substantially when potential confounding factors were included in the models, we consider that our findings are unlikely to result from residual confounding. Our results are based on a secondary analysis of a trial of DHA supplementation during pregnancy. Although DHA supplementation in mothers was not substantially associated with adiposity or with cardiometabolic markers in the offspring at 4 y of age (42), we adjusted for treatment assignment in the analyses.
The timing of introduction of solid foods (43) was less extensively studied in relation to child obesity than BF. Our results did not change when we adjusted additionally for the type of food given to the non-EBF infants.
Possible mechanisms for the inverse associations found between BF with adiposity and cardiometabolic risk indicators include self-regulation of energy intake in breastfed infants in comparison with formula-fed infants (44) (45) (46) , less consumption of protein in breastfed children than formula-fed children, resulting in breastfed infants having lower insulin secretion and insulin growth factor I and less weight gain during the first 2 y of life (47); better regulation of appetite, resulting from the activity of adipokines (leptin and adiponectin) present in breast milk, which in turn could help regulate long-term body weight, improve sensitivity to insulin, and increase FA metabolism (48, 49) ; and early exposure to dietary cholesterol in breast milk, which may lead to the regulation of cholesterol during later stages of life (50) . Some limitations of the present study should be considered. Blood samples were nonfasting, and TG, insulin, and glucose serum concentrations are related to the time since the last meal and the quantity and composition of food eaten. We adjusted all models for time since last food consumption at the time of blood drawing. Furthermore, duration of fasting was similar across BF groups.
Another limitation was attrition. During the course of the study 37.2% and 54.2% of children from the original cohort at birth were lost to follow-up at 4 y (n = 246) or were excluded from our analysis due to missing data on adiposity (n = 116) and/ or cardiometabolic markers (n = 78). However, comparison of the sample analyzed and those excluded from analysis suggest that losses to follow-up or missing data were generally random and are unlikely to have biased the estimates. Furthermore, all models were adjusted for all variables of interest for this study; therefore, it is unlikely that these differences affect our results.
The observational design of the study does not allow inference of causality. Nevertheless, the prospective nature of this cohort study and adjustment for several known and plausible confounding factors minimize the potential for bias and support the plausibility of causal associations.
Some strengths of our study should also be considered. It is one of the first studies conducted in a middle-income country to analyze the relation between BF and adiposity and cardiometabolic markers in a contemporary cohort. Detailed neonatal and postnatal anthropometric measures were available to assess the relations among BF, adiposity, and cardiometabolic markers. Data were obtained prospectively to reduce the risk of misclassification due to recall of BF status. Duration of BF was obtained at 24 mo, maternal recall was found to be reliable and valid if it is ascertained up to age 3 y (51).
In conclusion, the present study provides evidence of an association between adherence to recommended infant feeding patterns (EBF and PreBF at 3 mo of age and total duration of BF >12 mo) and lower adiposity and improved cardiometabolic markers in a contemporary cohort of Mexican children. 2 For adiposity and lipid profiles outcomes total effects are presented only. Total effects correspond to direct effects, because no significant indirect effects were found in these models. 3 Adjusted by BMI of mother at weeks 18-22 of pregnancy, birth weight of the child, maternal smoking during pregnancy (obtained at weeks [18] [19] [20] [21] [22] , maternal education, socioeconomic status, DHA treatment, and sex and age of the child (n = 611). 4 Additionally adjusted for hours of fasting (n = 446). 5 Additionally adjusted for hours of fasting (n = 467). 6 Additionally adjusted for hours of fasting (n = 457).
